NUVB

NUVB

USD

Nuvation Bio Inc. Class A Common Stock

$4.830-0.320 (-6.214%)

实时价格

Healthcare
生物技术
美国

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$5.150

最高价

$5.190

最低价

$3.920

成交量

6.20M

公司基本面

市值

1.7B

所属行业

生物技术

国家/地区

United States

交易统计

平均成交量

7.11M

交易所

NYQ

货币

USD

52周价格范围

最低价 $1.54当前价 $4.830最高价 $5.55

相关新闻

Analyst Upgrades

RBC Capital Maintains Outperform on Nuvation Bio, Raises Price Target to $8

RBC Capital analyst Leonid Timashev maintains Nuvation Bio with a Outperform and raises the price target from $7 to $8.

查看更多
RBC Capital Maintains Outperform on Nuvation Bio, Raises Price Target to $8
BusinessWire

Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update

Successfully started 204 patients on IBTROZI™ (taletrectinib) in the third quarter of 2025 Updated data continue to show IBTROZI's unprecedented durability in TKI-naïve, advanced ROS1-positive (ROS1+) non-small

查看更多
Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
BusinessWire

Nuvation Bio to Participate in Upcoming Investor Conferences

Nuvation Bio Inc. (NYSE:NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that David Hung, M.D., Founder, President, and Chief Executive Officer of

查看更多
Nuvation Bio to Participate in Upcoming Investor Conferences